Archive Press Releases

17.12.2009
Epigenomics AG: PRESEPT Study Subject Enrollment Successfully Completed
PDF 79 KB
 
10.11.2009
Epigenomics AG Reports Q3 and Nine Months 2009 Results
PDF 93 KB
 
02.11.2009
Epigenomics AG: U.S. Development Partner Quest Diagnostics Completes Clinical Development of Septin9 Colorectal Cancer Blood Test
PDF 60 KB
 
08.10.2009
Epigenomics AG Initiates Testing of Blood Plasma Samples from PRESEPT Study in Three Independent Clinical Laboratories
PDF 80 KB
 
06.10.2009
Epigenomics AG Launches its Epi proColon Product in Europe - the First Ever In Vitro Diagnostic Blood Test for Colorectal Cancer Early Detection
PDF 85 KB
 
21.09.2009
Epigenomics AG: First Blood Test for Colorectal Cancer Available in Germany
 
25.08.2009
Epigenomics AG: Clinical Study Shows Lead Biomarker for Lung Cancer also works in Blood
 
17.08.2009
Epigenomics AG Licenses Biomarker for Colorectal Cancer Blood Test to ARUP Laboratories
 
11.08.2009
Epigenomics AG Reports First Half 2009 Results
 
20.07.2009
DxS and Epigenomics Cross-License Technology for In Vitro Diagnostics
 
30.06.2009
Epigenomics AG Certified for Diagnostic Product Development and Commercialization
 
25.06.2009
Epigenomics AG Presents Colorectal Cancer Blood Test at ESMO Conference
 
23.06.2009
Swiss Viollier AG First Laboratory in Europe to offer Epigenomics' Colorectal Cancer Blood Test
 
02.06.2009
Epigenomics AG reports progress in clinical development of its colorectal cancer blood test during Digestive Disease Week
 
29.05.2009
Epigenomics AG Presents Clinical Data from Prostate Cancer Prognosis Study at ASCO
 
26.05.2009
Novel German Research Alliance to Detect Precursors of Colorectal Cancer - Munich Technical University, Epigenomics AG and KVB to develop novel approaches to cancer prevention
 
13.05.2009
Epigenomics AG Receives Allowances for Key Patents in Europe
 
11.05.2009
Epigenomics AG Reports First Quarter 2009 Financial Results
 
28.04.2009
Epigenomics AG Licenses Biomarker for Development of Prostate Cancer Test to Predictive Biosciences
 
31.03.2009
Epigenomics AG Reports Financial Results for the Fiscal Year 2008
 
18.03.2009
Epigenomics AG Moves Lung Cancer Test into Development after Successful Clinical Evaluation
 
11.03.2009
Epigenomics AG to host Press Conference and Analyst Meeting for 2008 Annual Results
 
25.02.2009
Epigenomics AG Licenses Biomarker for Development of Prostate Cancer Test to Quest Diagnostics
 
12.02.2009
Epigenomics AG Successfully Places Shares at Premium in Capital Increase
 
22.01.2009
Sysmex and Epigenomics AG Announce Strategic R&D Collaboration in Colorectal Cancer Diagnostics
 
1-25 26-50 51-75 76-100 101-124 Next >